Diffuse large B-cell lymphoma: Experience from a tertiary care center in North India

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 310-318

  Khera, Rohan ^a   Jain, Snigdha ^a   Kumar, Lalit ^a   Thulkar, S ^a   Vijayraghwan, M ^a   Dawar, R ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Diffuse large B cell lymphoma; India; Lymphoma; Non Hodgkin's lymphoma; Prognostic factors

Indexed keywords

ALBUMIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; IFOSFAMIDE; MESNA; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; ERYTHROCYTE SEDIMENTATION RATE; EVENT FREE SURVIVAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIA; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC PROTOCOLS; CANCER CARE FACILITIES; CHILD; FEMALE; HUMANS; INDIA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERTIARY PREVENTION; YOUNG ADULT;

EID: 77956906938     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9211-2     Document Type: Article

References (24)

1. Cancer incidence in five continents. Volume VII. IARC scientific publications. 1997;143:i-xxxiv, 1-1240.
2. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer. 1992;70(4):840-9. doi:10.1002/1097-0142 (19920815)70:4\840::AID-CNCR2820700420[3.0.CO;2-I.
3. Mitterlechner T, Fiegl M, Muhlbock H, Oberaigner W, Dirnhofer S, Tzankov A. Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000. J Clin Pathol. 2006;59(1):48-55. doi:10.1136/jcp.2005.026815. (Pubitemid 43076238)
4. Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Non-Hodgkin's lymphoma in the Netherlands: results from a population-based registry. Leuk Lymphoma. 2003;44(3):451-8. doi:10.1080/1042819021000038010. (Pubitemid 36113888)
5. Cowan RA, Jones M, Harris M, Steward WP, Radford JA, Wagstaff J, et al. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Br J Cancer. 1989;59(2):276-82.
6. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9(7):717-20. doi:10.1023/ A:1008265532487.
7. Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch Pathol Lab Med. 2008;132(1):118-24.
8. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. NEJM. 1993;328(14):1002-6. 8.
9. Jagarlamudi R, Kumar L, Kochupillai V, Kapil A, Banerjee U, Thulkar S. Infections in acute leukemia: an analysis of 240 febrile episodes.Med Oncol. 2000;17(2):111-6. doi:10.1007/BF02796205.
10. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17 (4):1244.
11. Hampson FA, Shaw AS. Response assessment in lymphoma. Clin Radiol. 2008;63(2):125-35. doi:10.1016/j.crad.2007.10.005.
12. Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, et al. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. Eur J Haematol. 2008;81(6):448-53. doi:10.1111/j.1600-0609.2008.01129.x.
13. Garg A, Dawar R, Agarwal V, Rustagi RK, Kochupillai V. Non- Hodgkin's lymphoma in northern India. A retrospective analysis of 238 cases. Cancer. 1985;56(4):972-7. doi:10.1002/1097-0142 (19850815)56:4<972::AID- CNCR2820560445>3.0.CO;2-V.
14. Indian council of Medical Research. National Cancer Registry Programme Consolidated report of the population based cancer registries 1990-1996: incidence and distribution of cancer. Indian Council of Medical Research, New Delhi 2001.
15. Intragumtornchai T, Wannakrairoj P, Chaimongkol B, Bhoopat L, Lekhakula A, Thamprasit T, et al. Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer. 1996;78(8):1813-9. doi:10.1002/(SICI)1097- 0142(19961015)78:8\1813::AID-CNCR24[3.0.CO;2-#.
16. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene. 2004;23(38):6524-34. doi:10.1038/sj.onc. 1207843.
17. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84(1):1-12. doi:10.1007/s00277-004-0939-7. (Pubitemid 39625035)
18. Tubbs RR, Fishleder A, Weiss RA, Savage RA, Sebek BA, Weick JK. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. Am J Pathol. 1983;113(2): 207-21.
19. Yang K. A histopathologic and immunopathologic study of 209 malignant lymphoma cases from four regions of China: Suzhou, Nanjing, Qingdao and Shenyang. Zhonghua Zhong Liu Za Zhi [Chin J Oncol]. 1993;15(2):86-90.
20. Kushwaha MR, Chandra D, Misra NC, Misra PK, Agarwal SS. Leukaemias and lymphomas at Lucknow, India. Leuk Res. 1985;9(6):799-802. doi:10.1016/0145- 2126(85)90295-4. (Pubitemid 15059132)
21. Shih LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hematol Oncol Clin North Am. 1991;5(5):983-1001.
22. Hasselblom S, Ridell B, Nilsson-Ehle H, Andersson PO. The impact of gender, age and patient selection on prognosis and outcome in diffuse large B-cell lymphoma-a population-based study. Leuk Lymphoma. 2007;48(4):736-45. doi:10.1080/ 10428190601187703. (Pubitemid 46605546)
23. Nakamura S, Lymphoma Study Group of Japanese Pathologists. The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50(9):696-702. doi:10.1046/j.1440-1827.2000.01108.x.
24. Piankijagum A, Pacharee P, Wasi P. Malignant lymphomas in Thailand: an analysis of 1095 cases. J Med Assoc Thai. 1980; 63(4):181-91.